A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00048217 |
Recruitment Status
: Unknown
Verified July 2004 by Trimeris.
Recruitment status was: Active, not recruiting
First Posted
: October 30, 2002
Last Update Posted
: June 24, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Drug: T-1249 | Phase 1 Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Completion T1249-102;
- Currently failing a T-20 containing regimen
Exclusion Criteria:
- Non-completion of T1249-102.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00048217
United States, North Carolina | |
Trimeris | |
Durham, North Carolina, United States, 27707 |
ClinicalTrials.gov Identifier: | NCT00048217 History of Changes |
Other Study ID Numbers: |
T1249-105 |
First Posted: | October 30, 2002 Key Record Dates |
Last Update Posted: | June 24, 2005 |
Last Verified: | July 2004 |
Keywords provided by Trimeris:
Treatment Experienced |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |